Treatment resistant depression: methodological overview and operational criteria.
about
The level of recognition of physical symptoms in patients with a major depression episode in the outpatient psychiatric practice in Puerto Rico: an observational study.Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depressionTreatment-resistant depression: critique of current approachesCharacterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims databaseBanking the brain. Addressing the ethical challenges of a mental-health biobankExamination of the utility of psychotherapy for patients with treatment resistant depression: a systematic review.Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder.A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy.Impact of a Student Pharmacist Driven Medication Reconciliation and Antidepressant Treatment History Project at a Depression Clinic: A Pilot StudyTreatment-resistant depression in primary care across CanadaCurrent nosology of treatment resistant depression: a controversy resistant to revisionA randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agExtrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly.Effectiveness of cognitive behavioural therapy augmentation in major depression treatment (ECAM study): study protocol for a randomised clinical trial.Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala.Age-associated decrease in global DNA methylation in patients with major depression.The pharmacological management of depressionTreatment strategies to improve and sustain remission in major depressive disorder.Therapy of treatment resistant depression: focus on the management of TRD with atypical antipsychotics.Treatment-resistant depression: therapeutic trends, challenges, and future directions.How an internist should deal with psychotropic drugs?The effectiveness of psychological treatments for treatment-resistant depression: a systematic review.Acute exercise improves physical sexual arousal in women taking antidepressants.The potential of transcranial photobiomodulation therapy for treatment of major depressive disorder.VNS and depression: current status and future directions.Combination pharmacotherapy in unipolar depression.Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods.Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview.A review of quetiapine in combination with antidepressant therapy in patients with depression.Mechanisms of antidepressant resistanceApoptosis-related proteins and proliferation markers in the orbitofrontal cortex in major depressive disorder.Therapeutic options in treatment-resistant depression.Neurostimulation therapies for treatment resistant depression: a focus on vagus nerve stimulation and deep brain stimulation.The hidden third: improving outcome in treatment-resistant depression.Staging of mental disorders: systematic review.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders.Treatment-resistant depression: are animal models of depression fit for purpose?Resilience dysregulation in major depressive disorder: focus on glutamatergic imbalance and microglial activation.Is treatment-resistant depression a useful concept?Evidence-based pharmacotherapy of treatment-resistant unipolar depression.
P2860
Q24810924-F6957657-C8C6-47AB-8596-C4F07788D4D4Q28084183-948C1721-7DB4-4EB0-892A-E36F9A8C7E5CQ28290605-8FAC421C-7DFB-43B2-B180-C188153B6EF4Q28534539-29DE8FDB-7947-4C0B-8F25-139FA2A14F72Q28706268-262AE41A-2909-4F42-959F-973F3DE032B1Q29036387-E8EB9870-A7C5-4C34-84AC-9662F4867FE3Q33389974-3145045E-0B4E-4312-88C3-71C5EE256265Q33658525-C7E04022-F931-4274-8F0F-AC90D4BF95D4Q33802913-E654AD44-A8D6-4BDA-9F1D-15C87B5DB721Q33861601-30B907EA-4866-467E-BA6C-B1AD1A88C8D6Q33920910-68CD1CDC-9746-494E-9272-7BDA162BF461Q34041642-04D30620-59DB-47D6-BDD9-04F69DB2C4CAQ34228583-C172D4EF-C5A9-40AC-A6BD-A65EDE5F6324Q34397198-3F045095-7757-49A4-8F18-678F993FA940Q34446887-C6627340-3276-43C1-A819-CE9AAABD38BAQ34530455-310182F1-A384-4D79-96C4-8B342E1017B3Q35236630-1B80D789-4760-4517-B4CC-35502037F3FEQ35237047-E83113E7-C6E3-44AE-9E5A-08D0C4072465Q35936252-BC4B2EF2-4515-498B-93A1-C372182A3108Q35997448-69F83690-04AE-403D-BC1C-B5D5033997B0Q36004848-66855F7D-4CD4-47BE-91A2-D7506FA8CBA9Q36093356-D9CD8E5F-618C-4A54-8848-678227E88683Q36172993-5B8C86B3-747F-4F07-BEC8-A6C77B3CEAD2Q36288255-732BF87B-549C-460F-BF62-0CC0488FA7EDQ36314948-1B2EECA4-B343-40CE-B7EC-F1F8E38C1BAAQ36532163-FABD1F52-06F9-4362-BA59-4F5EF26675F2Q36795521-FDFC4AD0-4B39-44BA-B164-6B0F4B3B94F1Q37091883-B9E9E590-6DA7-4243-85E8-1CB612D5E2B8Q37129835-818D90A1-081C-4236-A35B-BA94950B0CA3Q37334088-148B9946-6C77-4B73-B75B-C12B075725DAQ37718525-FC6DB48A-2A48-46D6-96E3-C6DABF64F5DEQ37881968-AFE773B6-15AC-45AD-96B0-007CC60DCE14Q37971399-6FABC510-E0A3-4B4E-A908-7D1140CD1E4BQ37974998-ADDA24F1-024A-4FBF-A03D-7DD6F9CD3322Q38059378-56ACB745-52CA-4C76-803F-895F84662CCAQ38123516-C20F686E-DA26-4EE4-A9E5-CA4CD690F6AFQ38569708-1484BD66-2FEE-4DAF-85D4-34CE298C3C68Q38694251-BA5F4B2F-2B17-4047-88A2-159F9CF10A79Q38696595-01540CF3-3C92-4F53-A9E6-B5E6BD90EE37Q39009865-E075966E-76C2-4962-B9C4-F7562283F749
P2860
Treatment resistant depression: methodological overview and operational criteria.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Treatment resistant depression: methodological overview and operational criteria.
@ast
Treatment resistant depression: methodological overview and operational criteria.
@en
Treatment resistant depression: methodological overview and operational criteria.
@nl
type
label
Treatment resistant depression: methodological overview and operational criteria.
@ast
Treatment resistant depression: methodological overview and operational criteria.
@en
Treatment resistant depression: methodological overview and operational criteria.
@nl
prefLabel
Treatment resistant depression: methodological overview and operational criteria.
@ast
Treatment resistant depression: methodological overview and operational criteria.
@en
Treatment resistant depression: methodological overview and operational criteria.
@nl
P2093
P1476
Treatment resistant depression: methodological overview and operational criteria.
@en
P2093
Amsterdam J
Lecrubier Y
Mendlewicz J
Montgomery S
de Montigny C
P356
10.1016/S0924-977X(98)00004-2
P407
P577
1999-01-01T00:00:00Z